Prosecution Insights
Prosecution Insights
Technology area: Medical Devices & Mechanical Engineering
3 pending office actions • 1 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
Maxwell Biomedical Inc. is managing 3 pending office actions in the Medical Devices & Mechanical Engineering technology area. All of these actions are concentrated within 1 distinct art unit, which suggests that the company's applications are being reviewed by a single specialized technical group. This concentration in 1 distinct art unit can lead to a more consistent examination experience, as the reviewers likely share similar technical expertise and follow the same internal guidelines for medical device applications. The 3 pending office actions represent the company's current efforts to expand its intellectual property in this field.
OKONAK, ELIZABETH LOUISE is the busiest examiner for the company, currently handling 1 pending office action. The workload is evenly split among 3 distinct examiners, with each individual responsible for exactly 1 pending matter. This distribution among 3 distinct examiners reduces the risk of the portfolio being stalled by the specific tendencies of a single reviewer. The company's strategy involves a balanced interaction with multiple examiners while maintaining a tight focus on the technical standards of 1 distinct art unit. This ensures that no single examiner has a concentrated influence over the company's pending applications.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §102 only | 1 (33%) |
| Multi-statute (no §101) | 2 (67%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| OKONAK, ELIZABETH LOUISE | 1 | 16.7% | +83.3% |
| WU, TONG E | 1 | 70.8% | +15.1% |
| ANJARIA, SHREYA PARAG | 1 | 53.7% | +26.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18870807 | CARDIAC TREATMENT SYSTEM | OKONAK, ELIZABETH LOUISE | — |
| 17925821 | PACING AND SENSING DEVICES AND CONTROL SYSTEM | WU, TONG E | — |
| 17908002 | CARDIAC PACING DEVICE | ANJARIA, SHREYA PARAG | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18870807 | CARDIAC TREATMENT SYSTEM | OKONAK, ELIZABETH LOUISE | — |
| 17925821 | PACING AND SENSING DEVICES AND CONTROL SYSTEM | WU, TONG E | — |
| 17908002 | CARDIAC PACING DEVICE | ANJARIA, SHREYA PARAG | — |
| Art Unit | Apps |
|---|---|
| 3796 | 2 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18870807 | CARDIAC TREATMENT SYSTEM | OKONAK, ELIZABETH LOUISE | — | §102 | Non-Final OA | — | Pending | Dec 02, 2024 |
| 17925821 | PACING AND SENSING DEVICES AND CONTROL SYSTEM | WU, TONG E | 3796 | §102§103§112 | Non-Final OA | — | Pending | Nov 16, 2022 |
| 17908002 | CARDIAC PACING DEVICE | ANJARIA, SHREYA PARAG | 3796 | §103§112 | Non-Final OA | — | Pending | Aug 30, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial